0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Hypotensive Sequelae of Diazoxide and Hydralazine Therapy

William L. Henrich, MD; Robert Cronin, MD; Paul D. Miller, MD; Robert J. Anderson, MD
JAMA. 1977;237(3):264-265. doi:10.1001/jama.1977.03270300068010.
Text Size: A A A
Published online

DIAZOXIDE (Hyperstat), a nondiuretic, benzothiadiazine vasodilator, has been shown to be a potent and rapidly effective hypotensive agent.1 The promptness of the hypotensive effect of diazoxide and the infrequency of adverse reactions following injection has led to widespread use of this agent in the treatment of hypertensive emergencies.1

We have recently seen, in consultation, four patients in whom severe hypotension followed diazoxide therapy. In each case, another vasodilatory agent, hydralazine hydrochloride, had been administered in close sequence to diazoxide therapy. Additionally, two of the four patients had received potential catecholaminedepleting agents while they were outpatients.

The present communication serves to emphasize that combinations of diazoxide and other vasodilatory or catecholamine-depleting agents may result in extreme hypotension.

Report of Cases 

Case 1.—  A 44-year old woman with a history of hypertension was admitted to the hospital with left chest pain and a blood pressure of 250/170 mm Hg. She

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();